Mycobacterial Metabolic Syndrome: LprG and Rv1410 Regulate Triacylglyceride Levels, Growth Rate and Virulence in Mycobacterium tuberculosis

• Amanda J. Martinot,

  Affiliation Division of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, United States of America

  ⨯
• Mary Farrow,

  Affiliation Division of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, United States of America

  ⨯
• Lu Bai,

  Affiliation Department of Chemistry, Stony Brook University, Stony Brook, New York, United States of America

  ⨯
• Emilie Layre,

  Affiliation Department of Medicine, Division of Immunology and Rheumatology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Tan-Yun Cheng,

  Affiliation Department of Medicine, Division of Immunology and Rheumatology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Jennifer H. Tsai,

  Affiliation Department of Chemistry, Texas A&M University, College Station, Texas, United States of America

  ⨯
• Jahangir Iqbal,

  Affiliation Department of Cell Biology, SUNY Downstate Medical Center, Brooklyn, New York, United States of America

  ⨯
• John W. Annand,

  Affiliation Department of Medicine, Division of Immunology and Rheumatology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Zuri A. Sullivan,

  Affiliation Division of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, United States of America

  ⨯
• M. Mahmood Hussain,

  Affiliation Department of Cell Biology, SUNY Downstate Medical Center, Brooklyn, New York, United States of America

  ⨯
• James Sacchettini,

  Affiliation Department of Chemistry, Texas A&M University, College Station, Texas, United States of America

  ⨯
• D. Branch Moody,

  Affiliation Department of Medicine, Division of Immunology and Rheumatology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Jessica C. Seeliger ,

  Contributed equally to this work with: Jessica C. Seeliger, Eric J. Rubin

  * E-mail: jessica.seeliger@stonybrook.edu (JCS); erubin@hsph.harvard.edu (EJR)

  Affiliation Department of Pharmacological Sciences, Stony Brook University, Stony Brook, New York, United States of America

  ⨯
• Eric J. Rubin

  Contributed equally to this work with: Jessica C. Seeliger, Eric J. Rubin

  * E-mail: jessica.seeliger@stonybrook.edu (JCS); erubin@hsph.harvard.edu (EJR)

  Affiliation Division of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, United States of America

  ⨯